Is estimated glomerular filtration rate superior to serum creatinine in predicting mortality on the waiting list for liver transplantation?
Open Access
- 1 March 2011
- journal article
- research article
- Published by Frontiers Media SA in Transplant International
- Vol. 24 (5) , 482-488
Abstract
Serum creatinine is an important prognostic indicator in patients on the liver transplant waiting‐list, being a component of the Model for End Stage Liver Disease (MELD) score. However, creatinine is influenced by age, gender and race, and in this role may disadvantage some individuals. The Modification of Diet in Renal Disease (MDRD) estimated glomerular filtration rate (eGFR) takes into account these variables and may be a superior measure of renal function. Our aim was to examine whether the MDRD 4‐variable, 5‐variable and 6‐variable eGFRs are superior to serum creatinine in predicting 3‐month waiting‐list mortality in patients with end‐stage liver disease. This was a retrospective single‐centre study of 427 adults listed for first liver transplantation. The median listing MDRD 4‐variable, 5‐variable and 6‐variable eGFR was 69, 71 and 73 ml/min/1.73 m2, respectively. The median listing serum creatinine was 89 μm. MDRD 4‐variable (P = 0.002), 5‐variable (P < 0.001) and 6‐variable eGFR (P < 0.001), and serum creatinine (P < 0.001), were all predictors of mortality on the transplant waiting‐list. Of the three MDRD equations, the 6‐variable eGFR was the better prognostic indicator. The substitution of 6‐variable eGFR for serum creatinine did not improve the prognostic accuracy of the MELD (P = 0.825) and UK score for Patients with End‐Stage Liver Disease (P = 0.781) scores. In conclusion the MDRD eGFR is comparable, but not superior to serum creatinine, in predicting death within 3 months of listing for liver transplantation.Keywords
This publication has 20 references indexed in Scilit:
- Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting ListNew England Journal of Medicine, 2008
- Review article: renal function assessment in cirrhosis – difficulties and alternative measurementsAlimentary Pharmacology & Therapeutics, 2007
- Female Liver Transplant Recipients with the Same GFR as Male Recipients Have Lower MELD Scores–A Systematic BiasAmerican Journal of Transplantation, 2007
- Serum sodium predicts mortality in patients listed for liver transplantationHepatology, 2004
- Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early deathHepatology, 2004
- Assessing renal function in cirrhotic patients: Problems and pitfallsAmerican Journal of Kidney Diseases, 2003
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shuntsHepatology, 2000
- Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†Hepatology, 1996
- Serum Creatinine and Renal FunctionAnnual Review of Medicine, 1988